Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CAROLINA SPINE CENTER PA

NPI: 1992938823 · ROCKINGHAM, NC 28379 · Physical Medicine & Rehabilitation Physician · NPI assigned 08/26/2009

$2.44M
Total Medicaid Paid
57,659
Total Claims
44,025
Beneficiaries
11
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialKNIGHT, MEGAN (PRACTICE MANAGER)
NPI Enumeration Date08/26/2009

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 6,710 $288K
2019 6,896 $302K
2020 6,107 $255K
2021 7,489 $343K
2022 9,065 $417K
2023 9,791 $384K
2024 11,601 $450K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 42,541 31,913 $1.23M
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 3,695 3,021 $580K
80307 6,950 5,700 $397K
64483 2,521 1,914 $183K
99204 646 475 $27K
99213 792 545 $13K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 125 115 $7K
64479 13 12 $763.53
20610 16 13 $763.01
64493 21 13 $726.02
J1100 Injection, dexamethasone sodium phosphate, 1 mg 339 304 $214.95